XML 41 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments and Contingencies (Details) - USD ($)
 3 Months Ended 9 Months Ended
Apr. 01, 2016
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Commitments and Contingencies (Textual)          
Lease expiration date       May 31, 2016  
Monthly lease rental payments       $ 9,000  
Operating leases, rent expense   $ 27,706 $ 15,286 71,606 $ 50,350
Salaries, wages and officers compensation       $ 145,000  
Stock option exercise price lower range limit       $ 0.40  
Stock option exercise price upper range limit       $ 0.80  
Stock issued during period performance based options to purchase common stock   4,400,000   4,400,000  
Percentage of bonus compensation for pretax income       15.00%  
Common stock issued for services as per agreement       $ 306,667  
Stock options, Expiration date       Dec. 31, 2017  
share price   $ 0.30   $ 0.30  
Two consultants [Member]          
Commitments and Contingencies (Textual)          
Common stock issued for services as per agreement $ 690,000        
Restricted Stock and Options [Member]          
Commitments and Contingencies (Textual)          
Consultant agreements Description      

The Company has entered into two agreements on April 1, 2016 with two consultants of Immudyne PR for business development, marketing and sales related services (the “Consultant Agreements”). Upon signing, each consultant was issued 1,000,000 restricted shares of Immudyne, Inc. common stock. In addition, each consultant shall receive an additional 150,000 restricted shares of Immudyne, Inc. common stock for each $500,000 distributed by Immudyne PR to the Company. For each consultant the amount of shares to be issued by the Company to the consultants shall be capped at 1,500,000 restricted shares when Immudyne PR has transferred $5,000,000 to the Company, for a combined capped total of 3,000,000 restricted shares. For the three and nine months ended September 30, 2016, 2,300,000 restricted shares of common stock have been issued related to these agreements.

   

In addition, the Consulting Agreements provided that each consultant shall receive a bonus of an additional 750,000 restricted shares of Immudyne Inc. common stock, plus an option to buy 1,000,000 shares of Immudyne, Inc. common stock at $0.20/share (including a cashless exercise feature) when Immudyne PR has transferred to the Company at each of the following three (3) thresholds: $1,250,000, $2,000,000 and $3,000,000 for a total of 2,250,000 of restricted shares of Immudyne, Inc. common stock and options to purchase up to 3,000,000 shares of Immudyne, Inc. common stock at $0.20/share. As of September 30, 2016, no bonus shares have been issued and no options have been granted under this agreement.

  
Restricted shares issued 1,000,000     2,300,000  
Option to buy shares       1,000,000  
Additional bonus shares       750,000